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Open letter to Tony Blair: Call to prevent escalating violence
Editor—Three important reports have
been published in the past month on the
humanitarian impacts of international vio›
lence and conflict.1–3 All provide evidence of
the short and long term adverse health
impacts of the use of force internationally.
The World Health Organization’s World
Report on Violence and Health is a detailed
assessment compiled over three years by
international health scientists.1 Collateral
Damage: The Health and Environmental Costs
of War on Iraq is a report of a study by
Medact, a UK charity of nurses, doctors, and
other health professionals.2 The latest report
released by the Campaign Against Sanc›
tions on Iraq (CASI) based at Cambridge
University, is a UN report on likely humani›
tarian scenarios of war on Iraq.3
Medact estimates that if the threatened
war on Iraq ensues, “total possible deaths on
all sides during conflict and in the following
three months will range from 48 000 to over
260 000. Civil war within Iraq could add
another 20 000 deaths. Additional later
deaths from postwar adverse health effects
could reach 200 000. In all scenarios the
majority of casualties will be civilians.” The
report calculates that “the aftermath of a
‘conventional’ war could include civil war,
famine and epidemics, refugees and dis›
placed people, and catastrophic effects on
children’s health and development.”
Knock›on effects could include exacerbation
of international conflicts, inequalities, and
divisions.
The most recent UN report also
estimates substantial and wide›reaching
humanitarian impacts: “As many as 500 000
people could require treatment to a greater
or lesser degree as a result of direct or indi›
rect injuries,” on the basis of the WHO’s esti›
mates of 100 000 direct and 400 000
indirect casualties. It indicates existing short›
ages of some medical items, “rendering the
existing stocks inadequate” for war increased
demand, and exacerbated by the “likely
absence of a functioning primary health
care system in a post›conflict situation.”
The report also “estimated that the
nutritional status of some 3.03 million
people countrywide will be dire and that
they will require therapeutic feeding
[according to Unicef ’s estimates].” Finally, “it
is estimated that there will eventually be
some 900 000 Iraqi refugees requiring
assistance, of whom 100 000 will be in need
of immediate assistance [according to the
United Nations High Commissioner for
Refugees (UNHCR)] . . . An estimated 2 mil›
lion people will require some assistance with
shelter.” For 130 000 existing refugees in
Iraq “it is probable that UNHCR will initially
be unable to provide the support required.”
But the most worrying impact of the use
of force in Iraq and internationally is in its
role as an escalator of collective violence.
The WHO defines “collective violence”—by
states or non governmental groups—as:
“The instrumental use of violence by people
who identify themselves as members of a
group—whether this group is transitory or
has a more permanent identity—against
another group or set of individuals, in order
to achieve political, economic or social
objectives.” The WHO reports that such col›
lective use of force has long term negative
impacts on stability and social wellbeing.
International violence has been steadily
increasing and “overall a total of 72 million
people are believed to have lost their lives
during the 20th century due to conflict, with
an additional 52 million lives lost through
genocides.” Conflict escalates after use of
collective force, as violence becomes a more
common and legitimated form of political
or social action.
Health professionals worldwide care for
the casualties of war. We accept this respon›
sibility. However, it is also our responsibility
to argue for prevention of violence and
peaceful resolution of conflict. Staff and stu›
dents of the London School of Hygiene and
Tropical Medicine come from and work in
over 120 countries, many in conflict. Our
experience and evidence corroborate the
views of the WHO, United Nations, and
Medact.
We believe that a war would have
disastrous short, medium, and long term
social and public health consequences—not
just for Iraq, but internationally. Conflict is
rooted in inequality and unjust governance.
Military intervention in Iraq, when there
remain so many peaceful routes to disarma›
ment, risks escalating collective violence.
The WHO argues that conflict can be
averted only by more equitable forms of
development and by accountable, ethical
governance internationally. We strongly
support this perspective and believe that
further acts of violence can be prevented by
international and local governance that
shows itself to be peaceful and ethical.
For the reasons above, we oppose the
use of military intervention in Iraq. We hope
this letter contributes to informed discus›
sion among members of the government
and the public. We also intend this statement
to support all those who are opposed to
military action on ethical and humanitarian
grounds, not originating from any political
or religious view point.
Carolyn Stephens senior lecturer in environment and
health policy, department of public health and policy
London School of Hygiene and Tropical Medicine,
London WC1E 7HT
carolyn.stephens@lshtm.ac.uk
On behalf of the staff, students, and alumni of
the London School of Hygiene and Tropical
Medicine, and in collaboration with Medact.
1 World Health Organization. World report on violence
and health. Available at www.who.int/violence_injury_
prevention/main.cfm?p=0000000682 (accessed 20 Jan
2003).
2 Medact. Collateral damage: the health and environmental
costs of war on Iraq. Available at: www.medact.org/tbx/
pages/sub.cfm?id=556 (accessed 20 Jan 2003).
3 Campaign Against Sanctions on Iraq (CASI). Internal UN
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Poor system design and little investment
mean hospital doctors do not use
computers . . .
Editor—Benson’s article neatly summarises
some of the difficulties hospital doctors have
using computers.1 I would enthusiastically
use computers in hospitals if seven points
applied.
(1) Computers were readily available.
(2) Security measures were sensible.
(3) Email could be picked up both in the
trust and at home or other work places.
(4) Patient details or past letters were
accessible so, for example, you could see an
emergency referral with some idea of what
had previously happened.
(5) Pathology results could be viewed
rapidly.
(6) Medical records were readily
accessible.
(7) Access to the internet was good
enough to allow, for example, reading of
medical journals.
These measures would empower doc›
tors and make computers useful. In the trust
where I work the IT department has been
starved of funds, is several hundred comput›
The names of the 500 signatories to this
letter are published on bmj.com.
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ers short, and is able to follow NHS
guidelines only to the letter, with the follow›
ing results.
(1) Seven junior doctors share one com›
puter.
(2) Passwords are changed every 14 days.
Many people forget their repeatedly
updated passwords and so the IT helpdesk
mainly deals with this problem (after the
required form has been filled in, signed by a
manager, and faxed to the desk). Alterna›
tively, people write down their passwords.
(3) NHSnet does not enable email to be
picked up at home, and external email can›
not easily be picked up in the trust.
(4) Patient details or past letters are
accessible only by secretaries or administra›
tors, apparently for security and confiden›
tiality reasons.
(5) Pathology results are on a different,
inaccessible, system.
(6) Patient notes are on another, also
inaccessible, system.
(7) Access to the internet is restricted.
Thus there is little incentive to use com›
puters in this NHS trust. Disappointingly,
the next tranche of investment of funds will
once again be top down. Inevitably, a large
information technology company will
devour scarce resources to generate a
system that works well for administrators
and is not used by doctors because it does
not do anything useful. However, I am sure
that it will be secure and provide countless
statistics.
What seems to be mainly lacking is
resolve. The solution would be to involve
doctors before designing or implementing a
system. Most importantly, they should be lis›
tened to, which currently does not seem to
happen.
Jan K Melichar clinical lecturer
University of Bristol, Bristol BS6 6JL
jan.melichar@bris.ac.uk
1 Benson T. Why general practitioners use computers and
hospital doctors do not—Part 2: scalability. BMJ
2002;325:1090›3. (9 November.)
. . . while limited and uncoordinated
development of information technology
curtails general practitioners
Editor—I am amazed by the limited and
uncoordinated development of information
technology in the NHS.
In our rural general practice we are com›
puter enthusiasts and have embraced every
new development. Although we have the
brand leader system, EMIS, we still cannot
transfer patients’ old notes electronically from
their former general practitioners. When a
patient joins our list we simply get a huge
printout, months later, from any paperless
practice the patient was with before.
We can obtain limited laboratory results
from the hospital electronically, but the
service remains unreliable. We receive only
the results for tests we have requested, not
those from tests ordered by consultants.
Similarly, consultants do not have access to
tests requested by general practitioners,
although the trust is one of the three nation›
wide electronic patient record sites.
When I add a vaccination to a computer
record it should automatically update the
health authority’s child immunisation
records and the local community trust’s
child health records. Instead I complete a
paper form and waste time every quarter
comparing our database manually with
those of the two organisations and upgrad›
ing them both.
We are also not linked to the hospital in
any meaningful way. I can email the world at
the touch of a button, but I cannot find out
from six miles (10 km) down the road basic
information such as changes in drug
treatment. We have tried to add all hospital
numbers to our system as we receive
correspondence, which is time consuming
and inefficient. However, global data are not
available to upgrade our system in one fell
swoop because the computers cannot talk to
each other under the Data Protection Act.
The health authority database is fairly robust
and has been linked to general practice sys›
tems for years, but the community trust and
hospitals are unable to access it. Thus we
continue to develop duplicate systems but
not the long planned national database
based on NHS numbers.
Primary care has generally led second›
ary care in computerisation, but if primary
care is not joined up, how can we expect
hospitals, all developing their own solutions
independently, to do any better? The
prospects for improved electronic commu›
nication between primary care and second›
ary care must be even more bleak.
Mark Bland senior partner
Crown Surgery, Eccleshall, Stafford ST21 6BW
Mark.Bland@sshawebmail.nhs.uk
Rethinking management
Fundamental rethink of medical
management is needed
Editor—Smith in his editorial on the rejec›
tion of the proposed consultant contract in
England and Wales cites as a principal cause
the widespread distrust among clinicians of
hospital managers.1 In the same edition,
Houghton et al identify a lack of adequate
training in writing business plans, negotiat›
ing change, and getting things done as
specific difficulties for newly appointed con›
sultants.2
Clinicians are often thrust into senior
management positions with major responsi›
bilities for substantial budgets without the
necessary financial know›how. A fundamental
rethink of medical management is called for.
What is needed is the development of a
distinct career track in medical management
at a much earlier stage, with the necessary
management training on a par with that
available in the commercial sector. This
model has worked well in Australia. Such
medical managerial posts will need adequate
sessional commitments for these managers to
provide a high quality of executive function. A
professional cadre of medically qualified
managers in touch with clinicians involved in
the delivery of service, setting realistic targets
for service delivery in partnership with lay
hospital managers, might restore the trust of
the medical profession and deliver the stand›
ards of care to which the government aspires.
Ian H Kunkler consultant in clinical oncology
Western General Hospital, Edinburgh EH4 2XU
I.Kunkler@ed.ac.uk
1 Smith R. Take back your mink, take back your pearls. BMJ
2002;325:1047›8. (9 November.)
2 Houghton A, Peters T, Bolton J. Career focus. What do new
consultants have to say? BMJ 2002; 325(classified
suppl):145›7. (9 November 2002.)
Changes seem to be ignored in health
industry
Editor—Smith’s analysis of the reaction to
the consultant contract does not address the
question “Have we got the role of manage›
ment right?”1
Although health services are clearly a
personal professional service industry,
reforms over the past decades have been
based largely on the production industry. In
the meantime, many other industries have
been realising that professional services,
with their central reliance on knowledge,
require a very different organisational struc›
ture and style of management than has been
traditionally accepted as the norm. These
changes entail a structural shift from hierar›
chy to networks, a change in relationships
from formal to informal, and shifts of power
from managers to the professionals.
Yet these changes seem to be ignored in
the health industry, which is moving further
towards formal hierarchical control. Why is
this?
F C Gray Southon honorary research associate
15 Parthenia Street, Caringbah, NSW 2229,
Australia
gray@southon.net
1 Smith R. Take back your mink, take back your pearls. BMJ
2002;325:1047›8. (9 November.)
Consistent criteria need to be applied to
rationing decisions
Editor—Smith notes that a central reason
for consultants rejecting the new contract
was the distrust of managers’ control and in
particular their pursuit of targets that distort
good care.1 Some consultants have claimed
that the target to reduce maximum waiting
times has led to managers pressuring them
to treat patients out of turn from the point of
view of clinical urgency.
This would be a very serious charge if it
was not demonstrably the case that a good
deal of variation exists between consultants’
clinical (for which also read, priority setting
or rationing) decisions when it comes to
admitting patients from their waiting list and
choosing which patients to add to their sur›
gical lists each week. The recent Audit Com›
mission report on access to ear, nose, and
throat services is just the latest evidence of
such variation.2 This showed that for
grommet operations, for example, all ear,
nose, and throat consultants in one trust
considered that no such operations needed
to be carried out within three months,
whereas in another trust the consultants
were of the reverse opinion.
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The point here—and the issue for
managers struggling to ensure that patients
do not wait unreasonable lengths of time for
their operations—is that more consistent
(and rational) criteria need to be applied to
key rationing decisions. Allowing all consult›
ants complete freedom to make such
decisions will not, on past and current
experience, lead to an equitable outcome for
patients in terms of waiting times.
As Smith rightly points out, however,
doctors, managers, and everyone else work›
ing in the NHS are all in this together.
Although no employee wants to feel
exploited, no one should take his or her eye
off the ball: patients are what matters, and
many, rightly, believe that they wait unneces›
sarily long periods of time for their NHS
care. The much derided government targets
on waiting times merely reflect what patients
want—and, it could be argued, what they
need in terms of their health.
John L Appleby chief economist
King’s Fund, London W1G 0AN
1 Smith R. Take back your mink, take back your pearls. BMJ
2002;325:1047›8. (9 November.)
2 Audit Commission. Access to care: ear, nose and throat and
audiology services. London: Audit Commission, 2002.
I’m losing my religion
Editor—Smith says that we must remember
that the future will depend on working
together.1 I think he is right for those who
want to stay and work together.
Working time directives; diminishing
numbers of applicants to medical schools;
gung›ho GMC malpractice lawsuits rising at
10›15% per year; a tidal wave of medical
legislation, regulations, and policies; quan›
gos dabbling left right and centre; the
shockwaves from Bristol and Shipman; a
sense of bullying as a means of getting
things done; racism; nepotism; massive spin
doctoring about everything under the sun;
regular media feeding frenzies when doctors
mess up—who, for all the love of money and
wonderful contracts, would want to take up
such work for the next 30 years? Exchange
glowing youth for a chance to have triple
bypass surgery—if you’re lucky?
Only the best. “The best of the best, of
course. Only those who love that challenge.
The go›getting type A personalities. Those
with real leadership qualities. Not the faint
hearted,” shouts some deluded spin doctor
from on high.
Somebody has got to do the job. It’s no
better anywhere else—is it? So, Mr Young
Bright Eyed and Bushy Tailed Doctor—go
for it. Trapped by a massive mortgage in a
superinflated housing market; a few mouths
that you feed but hardly ever see; your fancy
sports car; a significantly higher than
average risk of depression, alcoholism, and
suicide; a one in three (or better) chance of
eventually paying alimony or child support,
or both; and the noose of a big fat pension in
your later years—you’ll be a very good boy.
You’ll be right up there, working together
with them—rationing healthcare and
humanity. Good for you.
Some will create opportunities else›
where for a better lifestyle. Spare me the
mantras from “Improving working lives”—
too little, too late, and spin laden as usual.
I’m sure many more of us whingers who
care about our health and life expectancy
will follow, to places where we’re no obstacle
to progress or working together. Good for
us. Good for everyone.
Russell D Lutchman specialist registrar in forensic
psychiatry
Broadmoor Hospital, Crowthorne RG45 7EG
russl@orange.net
1 Smith R. Take back your mink, take back your pearls. BMJ
2002;325:1047›8. (9 November.)
Risk factors for cot death
increase danger from infection
Editor—Tappin et al found an increased
risk of the sudden infant death syndrome in
infants who slept on used mattresses, which
was further increased if the used mattress
was from another home.1 They say that the
increased risk might be associated with toxi›
genic species of bacteria, such as Staphylo›
coccus aureus, which grow well in body fluids
that contaminate mattresses.
We identified pyrogenic toxins of S
aureus in over half of the tissue samples from
infants who died of the sudden infant death
syndrome in five different countries.2 3 The
increased risk for sudden death associated
with used mattresses might be due in part to
colonisation of infants by toxigenic strains
against which the infants have no passive or
active immunity.
The higher risk associated with mat›
tresses obtained from other homes might be
related to introducing strains producing
toxins different from those colonising the
members of the infant’s immediate family.
Young infants obtain their normal flora
mainly from their mothers, from whom they
also obtain passive antibody protection
against these micro›organisms and their
toxins. We used an enzyme linked immuno›
sorbent assay (ELISA)3 to assess toxin
production among staphylococcal isolates
obtained from 106 infants dying of the sud›
den infant death syndrome and 150 healthy
infants. Among 116 pairs of S aureus isolates
from healthy infants and their mothers, 59
had the same pattern of toxin production.
The proportion of toxin producing isolates
was not significantly different in the infants
who died (55/106, 52%) and the healthy
infants (96/150, 64%) (P=0.052). The pro›
portions of specific toxins detected differed
significantly between the two populations
(÷2=21.62, df=3, P < 0.0001) (table).2
The increased risk associated with used
cot mattresses might be due in part to
increased exposure to toxigenic strains
against which the infant lacks antibodies, but
these observations must be assessed in
relation to other major risk factors such as
sleeping prone. Staphylococcal toxins cannot
be dismissed as postmortem contamination
because they are produced only between
37°C and 40°C, which is above the normal
nasopharyngeal temperature of children.
Overheating or minor respiratory infec›
tion might increase the nasopharyngeal tem›
perature to the range in which toxins are
produced. Children lying prone have notable
increases in nasal temperatures, and tempera›
tures of 37°C or higher have been recorded in
some after 30 minutes in the prone position.4
A large study of sudden infant death
syndrome in Scandinavia concluded that the
risk factors for the syndrome increase the
dangerousness of infection in infancy.5 The
findings of Tappin et al are another piece of
evidence to support this hypothesis.
C Caroline Blackwell conjoint professor
University of Newcastle, Newcastle, NSW 2300,
Australia
c_c_blackwell@hotmail.com
Anthony Busuttil professor, forensic medicine unit
Donald M Weir professor, medical microbiology
University of Edinburgh, Edinburgh EH8 9AG
1 Tappin D, Brooke H, Ecob R, Gibson A. Used infant
mattresses and sudden infant death syndrome in Scotland:
case›control study. BMJ 2002;325:1007›12. (2 November.)
2 Blackwell CC, Gordon AE, James VS, MacKenzie DA,
Mogensen›Buchanan M, El Ahmer OR, et al. The role of
bacterial toxins in sudden infant death syndrome (SIDS).
Int J Med Microbiol 2002;291:561›70.
3 Zorgani A, Essery SD, Madani OA, Bentley AJ, James VS,
MacKenzie DA, et al. Detection of pyrogenic toxins of Sta›
phylococcus aureus in cases of sudden infant death
syndrome. FEMS Immunol Med Microbiol 1999;25:103›8.
4 Molony N, Blackwell CC, Busuttil A. The effect of prone
posture on nasal temperature in children in relation to
induction of staphylococcal toxins implicated in sudden
infant death syndrome. FEMS Immunol Med Microbiol
1999;25:109›13.
5 Helweg›Larsen K, Lundemose, JB, Oyen, N Skjaerven R,
Alm B, Wennergren G, et al. Interaction of infectious
symptoms and modifiable risk factors in sudden infant
death syndrome. The Nordic epidemiological SIDS study.
Acta Paediatr 1999;88:521›7.
Long term effects of advice to
reduce dietary salt
Front cover was highly misleading
Editor—That small reductions in salt intake
(2 g/day) have a small but significant effect
on blood pressure is hardly surprising.1
Nevertheless, in populations this would have
a large effect on reducing strokes, heart
attacks, and heart failure.
Hooper et al do not ask why reducing
salt intake in the long term is so difficult.
They claim that the interventions used were
intensive, but most studies gave no details
Toxins detected in culture supernatant of Staphylococcus aureus strains isolated from healthy control
infants and infants dying of sudden infant death syndrome. Some strains produced more than one
toxin
Toxin
Infants with sudden infant death
syndrome (n=106) Control infants (n=150)
Staphylococcal enterotoxin A 13 (12.3) 41 (27.3)
Staphylococcal enterotoxin B 34 (32.1) 48 (32.0)
Staphylococcal enterotoxin C1 35 (33.0) 34 (22.7)
Toxic shock syndrome toxin 1 5 (4.7) 37 (34.7)
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about what advice was offered. Furthermore,
75% of salt intake comes from processed
food.2 This needs to be avoided or contain
less salt. None of the studies provided
reduced salt foods.
Interpreting the study by Hooper et al is
not helped by the editor writing the front
cover of the BMJ, who seems to have read a
different paper and misinterpreted the
important positive findings. The confusion is
increased by the authors’ press release,3 which
rightly blames the difficulty in reducing salt
intake squarely on the food industry.
This confusion is compounded by errors
in the meta›analysis. For example, the 18
month TOPH trial (phase I) was included as
an intervention trial over “60 months,” but
salt intake was reduced for only 18 months,
after which all participants returned to their
normal diet. References were misquoted,
and the correspondence following these
papers was ignored. The totality of evidence
for reducing salt is stronger than for any
other non›pharmacological treatment.
Ninety five per cent of the population are
at risk of developing cardiovascular disease,4
and 40% die from it. There are no controlled
trials showing a reduction in mortality on
stopping smoking, reducing fat intake alone
(without fish oil supplements),
reducing salt intake, losing
weight, increasing fruit and
vegetable consumption, or
increasing exercise. For most
of these factors no attempt
has been made to conduct
long term trials, owing to the
innate difficulty of conducting
and funding such trials and,
now, the ethics of randomly
putting a group of people on
a high salt diet for the rest of
their lives. The question that
Hooper et al need to consider
is what strength of evidence is
needed to give dietary and
lifestyle advice to try to prevent cardiovas›
cular disease.
The study indicates the importance of
reducing salt intake in the population, even
by small amounts, particularly in treating
high blood pressure.5 The BMJ should pub›
lish a retraction of its misleading front cover
and read the authors’ press release.
Graham A MacGregor professor of cardiovascular
medicine
Feng J He cardiovascular research fellow
Blood Pressure Unit, St George’s Hospital Medical
School, London SW17 0RE
Competing interests: None declared.
1 Hooper L, Bartlett C, Davey Smith G, Ebrahim S. System›
atic review of long term effects of advice to reduce dietary
salt in adults. BMJ 2002;325:628›32. (21 September.)
2 Nestle M. Food politics—How the food industry influences
nutrition and health. London: University of California Press,
2002.
3 University of Bristol. New ways of reducing salt intake
needed to make a long›term impact on blood pressure.
Media release, 20 September 2002. http://bris.ac.uk/Depts/
Info›Office/news/archive/salt.htm (accessed 3 Dec 2002).
4 Beaglehole R. Global cardiovascular disease prevention:
time to get serious. Lancet 2001;358:661›3.
5 MacGregor GA, Markandu ND, Singer DRJ, Cappuccio FP,
Shore AC, Sagnella GA. Moderate sodium restriction with
angiotensin converting enzyme inhibitor in essential
hypertension: a double blind study. BMJ 1987;294:531›4.
Critical faculties should always be
exercised
Editor—The paper by Hooper et al on the
long term effects of advice to reduce salt
intake in adults adds nothing new to the lit›
erature.1 Substantial evidence accumulated
over several decades shows that reducing
salt intake lowers blood pressure.2
It has also been clear for many years that
advice targeted at individuals will not
produce substantial and sustained reduc›
tions in salt intake as most salt in the diet is
added by the food industry to processed
food such as bread, cooked meat, and break›
fast cereals.2 Data on mortality and cardio›
vascular events from sodium restriction
trials are indeed limited, an important issue
that has been highlighted repeatedly in the
literature in recent years.
The discussion section of the paper by
Hooper et al has elements of spin worthy of
tabloid journalism, with selective and uncriti›
cal citation of relevant papers and a lack of
context. The arguments seem largely based
on a simplistic, individually based model of
health promotion. Only cursory reference is
made to the fact that dietary salt restriction is
a population health issue that needs to be
tackled in populations, by both regulation
and collaborative work with
the food industry.
The authors raise the
spectre of possible harm
from sodium restriction, rais›
ing the possibility of adverse
effects on cardiovascular dis›
ease and all cause mortality.
This speculation, which goes
well beyond the clinical trial
data, is largely based on two
papers by Alderman et al
that are widely regarded as
methodologically flawed and
have been extensively criti›
cised in correspondence and
reviews.2–4 Hooper et al do
not cite the paper by Tuomilehto et al, which
links higher dietary salt intake with
increased risk of cardiovascular events and
increased mortality.5 Given that the current
high dietary salt intake among children and
adults can largely be attributed to salt added
to processed food at concentrations well in
excess of physiological requirements, the
notion that efforts to achieve modest reduc›
tions in salt intake will have adverse effects
on health is implausible to say the least.
Meta›analysis is a powerful tool, but it does
not absolve its practitioners from the need
to exercise their critical faculties.
Ivan J Perry professor of public health
Department of Epidemiology and Public Health,
Distillery House, University College Cork
i.perry@ucc.ie
Competing interests: None declared.
1 Hooper L, Bartlett C, Davey Smith G, Ebrahim S. System›
atic review of long term effects of advice to reduce dietary
salt in adults. BMJ 2002;325:628›32. (21 September.)
2 MacGregor G, de Wardener HE. Salt, blood pressure and
health. Int J Epidemiol 2002;31:320›7.
3 Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh
JH. Low urinary sodium is associated with greater risk of
myocardial infarction among treated hypertensive men
[see comments]. Hypertension 1995;25:1144›52.
4 Alderman MH, Cohen H, Madhavan S. Dietary sodium
intake and mortality: the National Health and Nutrition
Examination Survey (NHANES I). Lancet 1998;351:781›5.
5 Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tan›
skanen A, Pietinen P, et al. Urinary sodium excretion and
cardiovascular mortality in Finland: a prospective study.
Lancet 2001;357:848›51.
Salt needs to be reduced in
manufacturing and processing food
Editor—Hooper et al in their meta›analysis
of randomised trials of individual dietary
advice to reduce salt intake conclude that
such intervention will have little effect on
health.1 They do not satisfactorily distinguish
whether salt reduction itself confers only a
small benefit or a large one, but people do not
materially reduce their salt intake. As a result
readers may conclude from the paper that
reducing salt intake is unimportant.
This is not so. Reducing the current aver›
age salt consumption in Britain by 3 g/day
(about one third) would reduce average blood
pressure by about 5 mm Hg systolic in people
over 50 and thereby reduce the incidence of
heart attack and strokes by about 15% and
22% respectively.2 A reduction of 6 g/day
would reduce blood pressure by about twice
as much with a corresponding additional
reduction in the incidence of heart attacks
and stroke. Reducing salt intake generally
would thus have a major impact in the
prevention of cardiovascular disease.
The obstacle to prevention is that nearly
all the salt we eat is hidden, added to many
foods in manufacturing and processing. Only
about 15% is discretionary in that an
individual can alter his or her intake through
their own cooking and addition at meals. It is
not therefore surprising that trials of advising
people to reduce salt intake have little effect.
When salt intake is reduced blood
pressure falls. Trials that show this best were
not included in the meta›analysis of Hooper
et al. They were trials in which dietary advice
was reinforced by the provision of low salt
staple foods such as bread, a major contribu›
tor to hidden salt in the national diet.3–5
While the effect of avoiding discretionary
salt is small it is achievable and worth while.
Unfortunately it will have been underesti›
mated in the analysis of Hooper et al because
the trial participants included people who
had already taken steps to avoid using discre›
tionary salt, thereby diluting the effect.
The analysis of these trials by Hooper
et al and the conclusions drawn are un›
informative other than confirming the
observation that little is gained by individual
dietary advice. The public health challenge
is to reduce salt used in the manufacturing
and processing of food. Over 10›15 years,
salt intake could be reduced by two thirds.
This would cause no untoward effects and
confer substantial health benefits.
M R Law professor
m.r.law@qmul.ac.uk
N J Wald professor
Department of Environmental and Preventive
Medicine, Wolfson Institute of Preventive Medicine,
Barts and the London, Queen Mary’s School of
Medicine and Dentistry, Queen Mary, University of
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Authors’ reply
Editor—We asked, “What are the long term
effects on health and blood pressure of advice
to reduce dietary salt intake?” and not, as
commentators seem to imagine, “Can salt
reduction lower blood pressure?” or “What
would be the effect of reducing salt in pro›
cessed foods?” We showed that advice does
reduce urinary sodium excretion by about a
quarter and this produces a 1 mm Hg fall in
systolic blood pressure at 13›60 months.
Contrary to MacGregor and He’s asser›
tion, interventions provided by four studies
(including 3007 of the 3514 participants)
were well documented and highly intensive. It
was not an error to use the 60 month out›
comes of the TOHP phase I trial: although its
18 month intervention period had ended,
there was no indication that all participants
had returned to their normal diet. The point
of such intensive intervention is precisely to
encourage lifelong dietary change, and the
authors clearly felt this was the case as they
followed up participants to 60 months.
Potential harms of a reduced sodium diet
do need discussion. Raised concentrations of
low density lipoprotein cholesterol were
highlighted in Graudal et al’s systematic
review,1 and the evidence on mortality from
three large cohort studies should not be
dismissed as inconvenient. We cited the paper
by Tuomilehto et al, which showed protective
effects of low salt diets, to give a balanced
account of the debate and draw attention to
inconsistencies in the evidence.
We excluded short duration trials of salt
restriction because these are not relevant to
the question we posed and some may not be
generalisable. At least seven trials conducted
by MacGregor’s group have produced mean
blood pressure reductions that are greater
than the upper 95% confidence interval of
the effects found in meta›analysis of over 50
trials of salt restriction.2 The reasons for such
wide divergence remain of interest and have
not been adequately explained.3
Law and Wald’s estimate of the effect of
salt restriction on blood pressure is
extremely optimistic compared with other
systematic reviews and has been more often
cited (table).4 Their meta›analysis, which
included 78 studies of salt restriction, only
10 of which were randomised, uses its own
methodology.4 Effects about an order of
magnitude greater than those reported by
other meta›analyses were found.
Reduced sodium foods may be helpful.
Only one of the studies in our review
provided low salt foods for its intervention
group throughout and recorded large
reductions in blood pressure, but, as anti›
hypertensive drugs also altered during the
study, interpretation is difficult.
Lee Hooper lecturer in evidence based care and
systematic review
MANDEC, University Dental Hospital of
Manchester, Manchester M15 6FH
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Indian objection to export of
human tissue for research
Clarifications from authors of study
Editor—With reference to our recent paper
in the Proceedings of the National Academy of
Sciences on the mutation rate of mtDNA, Mur›
dur says that Indian scientists are accusing the
foreign researchers of violating the national
guidelines.1 2 He omitted, however, to make
any mention of the first author of our paper,
Lucy Forster, who is herself Indian, from
Kerala, where the thorium rich sand is
located. The research formed the basis for her
PhD dissertation.
None of the coauthors was aware of the
guidelines to which your correspondent
refers, neither have we now been able to find
any mention of them on the website of the
Indian Council of Medical Research. It is in
any case not likely that the research in ques›
tion as such would lead to a patent or other
commercial applications. It does, however,
lead to the interesting conclusion, relevant
to human population history, that some
high estimates for the mtDNA mutation rate
are not well founded.
Peter Forster study author
McDonald Institute for Archaeological Research,
University of Cambridge, Cambridge CB2 3ER
dap38@cam.ac.uk
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DNA mutations. Proc Natl Acad Sci 2002;99:13950›4.
Author’s reply
Editor—Forster makes two new points:
firstly, that I did not mention that the first
author of the paper, Lucy Forster, is an
Indian national, and secondly, that the
guidelines are not available on the website of
the Indian Council of Medical Research. His
third point, that this research has no
commercial application, is already covered
in the news story.
While I was working on the story, I
did bring up each of these points several
times during my interviews with health
officials and biologists in India who are accus›
ing them of breaching guidelines. According
to them, neither of these two points could be
used to justify the violation of the guidelines.
They said that researchers, whether Indian or
international, taking out biological samples
are expected to be aware of the guidelines.
One person whom I had interviewed, a senior
member of the bioethics committee of the
Indian Council of Medical Research, in his
response to this point, had said that
ignorance of law—in this case guidelines—is
never a valid excuse.
The absence of the guidelines on the
council’s website is unfortunate. I have
already quoted Indian researchers in the
story, saying that the Indian government has
failed to implement these guidelines.
The other point, that Lucy Forster is an
Indian national and that this work was part of
her PhD dissertation, also does not change
the story in any way. The fact remains, as Peter
Forster acknowledged during my telephone
interview with him, that no hospital or
research centre in India ever participated in
this study. The paper in Proceedings of the
National Academy of Sciences does not list any
collaborating Indian institution.1 It identifies
Lucy Forster as affiliated to the University of
Cambridge and to the University of Münster
Numbers of citations of five systematic reviews of salt restriction and blood pressure. Updated from
Swales5
Law et al Cutler et al Midgley Cutler Graudal
Blood pressure reduction (mm Hg) 10/5 1.7/0.97 1.0/0.01 1.9/1.1 1.2/0.26
24 h urinary sodium excretion (mmol/l) 100 76 100 76 160






1996 21 14 11
1997 32 20 33 12
1998 23 6 19 6 10
Total to 2002 226 93 150 60 74
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but not to any institution in India. Given that
background, health officials and researchers
here say that this is a case where foreign
researchers have used local knowledge and
expertise of an Indian national to access bio›
logical material from India.
Ganapati Mudur contributing correspondent
New Delhi, India
gsmudur@hotmail.com
1 Forster L, Forster P, Lutz›Bonengel S, Wilkomm H, Brink›
mann B. Natural radioactivity and human mitochondrial
DNA mutations. Proc Natl Acad Sci 2002;99:13950›4.
Problem is not that simple
Editor—After reading the news article by
Mudur, and Forster’s response to the same, I
would like to make a few points.1
Firstly, Mudur’s general statement that
Indian scientists are accusing the foreign
researchers of violating national guidelines
is unfortunate. The article raises a valid
point but does not address why the Indian
Council of Medical Research and other such
agencies have not monitored the export of
biological material from India.
But it is also not apparent why Forster
goes into a quasi›defence mode when he
responds back. The first author, Lucy
Forster, may be Indian by birth but that does
not automatically give her the right to use
biological material from India for research
conducted under the auspices of foreign
universities. She may have her PhD disserta›
tion out of this, but that does not qualify her
to use the material. So the statement about
her Indian origins is irrelevant.
Forster is candid about his team’s
ignorance of the guidelines but in a way
defends himself by the fact that the Indian
Council of Medical Research’s website did
not contain it. In developing countries such
as India, showcasing through the internet is
but a new concept. So anything and
everything about the Indian Council of
Medical Research is not available on its site.
This is an Indian reality with which
researchers on the ground ought to be
familiar, as they probably were about
currency conversion rates. Although their
work did not have commercial implications
that was known only after the publication
came in. Biological samples can be used for
research purposes in more than one way. So,
if the callous attitude of the Indian
establishment—to frame guidelines but not
to implement them—remains, then in future
biological materials may be taken out of
India for projects not as non›commercial as
Forster et al’s endeavour.
Garga Chatterjee fourth year medical student
Medical College, University of Calcutta, Calcutta
(Kolkata), India 700027
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Ethics dialogue between rich
and poor countries is overdue
Editor—The agreement of the recent meet›
ing organised by the European Group on
Medical Ethics—that there should be more
dialogue between rich and poor countries
on cross cultural ethical issues—is long over›
due.1 Experts on medical ethics in the devel›
oped world have consistently ignored
conditions under which health care is
provided in developing countries when
making recommendations on ethical codes
and guidelines, with the result that medical
ethics is given little attention in their medical
schools and may not be taught at all.
Recent UN intergovernmental confer›
ences have been critical about unethical
conduct by health professionals in develop›
ing countries towards vulnerable groups,
which include most women and adolescents,
many of whom now consult doctors only as
a last resort.
The experts concerned, including
those responsible for the Declaration of Hel›
sinki and the guidelines of the Council for
International Organisations of Medical Sci›
ences, seem not to have realised that most
people in the world live in developing
countries. Many of them attend traditional
healers—either exclusively or at the same time
as they are attending practitioners of Western
conventional medicine—and most do not
regard themselves as bound by the tenets of
Judaeo›Christian morality that form the basis
of standard guidelines and codes of ethics in
developed countries.
Those who have practised in developing
countries are not surprised that choice is
dictated by community elders or a woman’s
husband in communities where most people
are illiterate. The whole community and the
whole family, particularly husbands, are
expected to be involved in the illness of a
family member, who also expects this to be
the case. Confidentiality and consent as dealt
with in the standard ethical guidance
produced in developed countries are not
understood.
The disproportionate amount of atten›
tion paid by ethical experts to moral dilem›
mas arising from modern technology is
largely irrelevant in developing countries,
where such techniques are rarely possible or
practicable. The ethical issues, particularly
rights based issues, concerned with provid›
ing basic health care are, however, impor›
tant. Ethical rulings that have been formu›
lated without regard to local customs and
situations are unlikely to be respected.
The statement from the meeting that
the best available treatment (as defined by
rich countries) is meaningless in communi›
ties where there is no access to treatment of
any sort is only one example of the tunnel
vision of Western ethicists. The conse›
quences, in terms of restrictions on research
into crucially important developments such
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Issues relating to abortions are
complicated in Nigeria
Editor—Raufu’s news item drawing atten›
tion to Nigeria, where 20 000 deaths are
reported to occur every year as a result of
mostly illegal abortions, calls for definite
remedial action.1 I commend the dean of the
medical school at Benin University and the
Society for Gynaecology and Obstetrics in
Nigeria for drawing attention yet again to
this important cause of morbidity and mor›
tality in the country.
None of the responses to the news item
on bmj.com considered the complex social
and religious milieu in which Nigerians live.
It is not the absence or paucity of medical
expertise, health education, or activity by
non›governmental organisations that drives
pregnant girls to underground abortion
clinics. Very strong cultural and religious
stigmas are associated with extramarital sex
in all regions of the country: not only Islam
but also the Roman Catholic Church
strongly oppose liberalisation of abortion.
To legislate on abortion is a very tall order in
Nigeria.
Islam presents particular difficulties
because people who adhere to it are
bound absolutely by the teachings of the
Koran, which strictly forbids sex outside
marriage. Most Nigerians are Muslim, but
that is not the problem. Among Muslims, a
large body of people well versed in both
Western and Islamic education can
promote better understanding of the
Koran’s injunctions and the teachings of the
prophet Mohammed. Unfortunately, the
religious agenda has been hijacked by a
small body of ill informed fanatics who
prefer to misinterpret the facts. For
example, regarding the introduction of
Islamic sharia law in Nigeria, nowhere is it
mentioned in the Koran that people
convicted of fornication should be stoned
to death.
It is imperative to do something
about the appalling annual death rate from
abortion in Nigeria, but success can
come about only if the matter is
approached with due sensitivity and consid›
eration for these cultural and religious
factors.
Idris Mohammed chairman
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